Other Infections

EACS 2017: New European Guidelines Cover HIV, Hepatitis C, and Related Conditions

Everyone with HIV and hepatitis C virus (HCV) coinfection should receive direct-acting antiviral therapy for hepatitis C and should receive the same treatment regimens for hepatitis C as people with HCV monoinfection, new European guidelines issued at the 16th European AIDS Conference recommend.

alt

Read more:

EACS 2017: Fostemsavir Controls Viral Load in Half of People with Highly Drug-Resistant HIV

Fostemsavir, a new experimental attachment inhibitor, suppressed viral load in over half of participants with extensive drug resistance when added to a background regimen selected by resistance testing, Max Lataillade of ViiV Healthcare reported at the recent 16th European AIDS Conference in Milan.

alt

Read more:

EACS 2017: HIV Diagnoses in English Gay Men Have Been Falling Since 2014

A new analysis by Public Health England of testing rates and HIV diagnoses from all of England’s sexual health clinics shows that the decline in diagnoses is England-wide, started at least a year before the decline was first noticed at London's 56 Dean Street clinic, and is not restricted to gay men who test frequently.

alt

Read more:

EACS 2017: European Cure Review Concentrates on HIV Therapeutic Vaccines

A cure for HIV would almost inevitably have to involve a vaccine to improve the body’s natural ability to control HIV, speakers said at a recent seminar on European HIV cure research. The STEPS seminar, put on by the European AIDS Treatment Group (EATG) ahead of the European AIDS Conference in Milan in October, also heard that, in the words of EATG member and European Community Advisory Board chair Giulio Maria Corbelli, "Cure research reminds us of the importance of patient involvement from the very earliest phases of the development of treatment and prevention."

alt

Read more:

EACS 2017: High HIV Incidence from Non-Primary Partners and Low PEP and PrEP Use Seen in PARTNER Study

HIV incidence among the HIV-negative gay men in the PARTNER 1 and 2 studies, due to sex with partners outside their main relationship, was high, and very high among partners who admitted having condomless anal sex with non-primary partners, researchers reported at the recent 16th European AIDS Conference (EACS 2017) in Milan.

alt

Read more:

EACS 2017: Up to a Quarter of HIV-Negative Gay Men Attending 3 English Clinics Used PrEP in the Last Year

A prospective cohort study of gay men attending 3 clinics in southern England --56 Dean Street and Mortimer Market Centre in London and the Brighton & Hove SHAC (Sexual Health & Contraception) service -- have found that 23% of HIV-negative service users who responded to a follow-up questionnaire had used PrEP (pre-exposure prophylaxis) in the last year. These interim results from the AURAH2 study were presented recently at the 16th European AIDS Conference (EACS 2017) in Milan.

alt

Read more:

EACS 2017: European AIDS Clinical Society Strengthens HPV Vaccination Advice

The European AIDS Clinical Society (EACS) has recommended human papillomavirus (HPV) vaccination for everyone living with HIV aged under 26 and all men who have sex with men up to the age of 40.

alt

Read more:

Coverage of the 16th European AIDS Conference

HIVandHepatitis.com and NAM coverage of the 16th European AIDS Conference (EACS 2017), October 25-27 2017, in Milan.

alt

Read more:

EACS 2017: Swiss Study Examines When Gay Men Decided to Stop Consistent Condom Use

An innovative study presented at the 16th European AIDS Conference (EACS 2017) in Milan in October used a machine-learning algorithm (originally developed to help astronomers classify galaxies) to tease out whether there were specific groups of gay men within a large national cohort whose sexual risk behaviors followed similar trajectories over time, and if so, whether they were influenced by external factors such as new scientific data.

alt

Read more: